v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net (loss) for the period $ (44,387) $ (7,995)
Adjustments for:    
Change in fair value of earnout shares liability 7,628 510
Change in fair value of warrant liabilities 13,670 620
Other gain 0 (122)
Share based compensation 3,911 788
Fair value of private placement warrants 0 144
Accretion of convertible debt 0 43
Change in fair value of convertible note 0 40
Loss on equity facility issuances 724 80
Depreciation and amortization 200 3
Unrealized loss (gain) on equity securities 0 2
Non-cash lease activity (11) (4)
  (18,265) (5,891)
Change in working capital items, net of effects of acquired business:    
Deferred reimbursements 6,168 0
Other current assets (1,041) 836
Accounts payable and accrued liabilities 1,251 (820)
Net cash used in operating activities (11,887) (5,875)
CASH FLOWS FROM INVESTING ACTIVITIES    
Assets acquired in business combination (8,400) 0
Capitalized expenditures (19,207) (5)
Deposits (49) 0
Net cash used in investing activities (27,656) (5)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of capital stock 466,010 14,516
Debt repayments 0 (7,223)
Related party debt draws 0 504
Related party debt repayment 0 (504)
Deferred financing costs (691) 0
Share issue costs (30,069) (2,131)
Net cash provided by financing activities 435,250 5,162
Change in cash, cash equivalents, and restricted cash during the period 395,707 (718)
Cash, cash equivalents, and restricted cash, beginning of period 25,554 2,012
Cash, cash equivalents, and restricted cash, end of period 421,261 1,294
Supplemental cash flow information:    
Conversion of debt for common shares 0 501
Additions to construction in progress not yet paid 644 0
Value of warrants issued 0 2,262
Interest paid $ 0 $ 4